Workflow
*ST长药涉财报造假被立案,退市警报拉响索赔刻不容缓
Xin Lang Cai Jing·2025-11-10 08:18

Group 1 - The company *ST Changyao is under investigation by the China Securities Regulatory Commission (CSRC) for suspected false financial reporting, which has led to a significant drop in its stock price, hitting the 20% limit down on November 10 [1] - The investigation poses severe risks for the company, including potential forced delisting if found guilty of major violations under the Shenzhen Stock Exchange's rules [1] - The company is currently facing multiple delisting risks, compounded by deteriorating financial conditions, heavy debts, and serious deficiencies in corporate governance and internal controls [1] Group 2 - On January 20, 2025, the Intermediate People's Court of Shiyan City, Hubei Province, decided to initiate pre-restructuring for Changyao Holdings, although the process has faced difficulties and the deadline for restructuring has been extended [2] - There remains a risk of bankruptcy and liquidation if the restructuring fails, despite previous successful claims by investors due to fund misappropriation [2] - Investors who purchased shares during specific periods (March 30, 2019, to April 29, 2024, and before November 7, 2025) and incurred losses are eligible for compensation through legal channels [3]